Skip to main content
Caplight Logo









Shuwen Biotech

Shuwen Biotech

Private
DeqingHealthcare & Life Scienceshttps://shuwendx.com

Last Round

Series C

Extension

Jul 8, 2025

Total Funding Raised

$29.39M

Company Overview

Shuwen Biotech is a diagnostics company that develops and commercializes novel solutions for healthcare, specializing in oncology, women's health, and critical care.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Precision Medicine, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting, Hardware Sales

AI Layer

Non-AI

Keywords

in vitro diagnosticsIVDmolecular diagnosticsprecision medicinecompanion diagnosticslaboratory developed testsLDToncology diagnosticscancer subtypingmaternal-fetal healthqPCR assaynucleic acid extractionclinical laboratory servicesbiotech lab servicesdiagnostic kit manufacturing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Shuwen Biotech Comparables

Compare Shuwen Biotech with similar companies based on industry and business-model similarity.

Shuwen Biotech comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
New Genetron Holding Limited
79%
Agendia
77%
Amoy Diagnostics Co., Ltd.
76%

Shuwen Biotech Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series C ExtensionJul 8, 2025
Series BSep 9, 2021

Shuwen Biotech Investors

Notable investors and investment history

Shuwen Biotech investors
InvestorRounds
Wuxi Capital GroupSeries B
YuanBio Venture CapitalSeries C Extension
Anyuan FundSeries B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 14, 2025

    Grew 25% QoQ, from 12 to 15 employees.

  • Jul 8, 2025

    $14M round led by YuanBio Venture Capital.

Shuwen Biotech Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Shuwen Biotech Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Shuwen Biotech's valuation, stock price, and market status.

Firmographic Details

HeadquartersDeqing
Employee Range11
Year Founded2011
Last FundingJul 8, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?